These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Regulation of fibrosis in muscular dystrophy. Smith LR; Barton ER Matrix Biol; 2018 Aug; 68-69():602-615. PubMed ID: 29408413 [TBL] [Abstract][Full Text] [Related]
33. Gene therapy for muscular dystrophy: lessons learned and path forward. Mendell JR; Rodino-Klapac L; Sahenk Z; Malik V; Kaspar BK; Walker CM; Clark KR Neurosci Lett; 2012 Oct; 527(2):90-9. PubMed ID: 22609847 [TBL] [Abstract][Full Text] [Related]
34. Influence of immune responses in gene/stem cell therapies for muscular dystrophies. Farini A; Sitzia C; Erratico S; Meregalli M; Torrente Y Biomed Res Int; 2014; 2014():818107. PubMed ID: 24959590 [TBL] [Abstract][Full Text] [Related]
35. An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases. Rodrigues M; Yokota T Methods Mol Biol; 2018; 1828():31-55. PubMed ID: 30171533 [TBL] [Abstract][Full Text] [Related]
36. Genetic modifiers of muscular dystrophy: implications for therapy. Heydemann A; Doherty KR; McNally EM Biochim Biophys Acta; 2007 Feb; 1772(2):216-28. PubMed ID: 16916601 [TBL] [Abstract][Full Text] [Related]
37. Progress in muscular dystrophy research with special emphasis on gene therapy. Sugita H; Takeda S Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(7):748-56. PubMed ID: 20689232 [TBL] [Abstract][Full Text] [Related]
38. Respiratory insight to congenital muscular dystrophies and congenital myopathies and its relation to clinical trial. Fauroux B; Amaddeo A; Quijano-Roy S; Barnerias C; Desguerre I; Khirani S Neuromuscul Disord; 2018 Sep; 28(9):731-740. PubMed ID: 30097248 [TBL] [Abstract][Full Text] [Related]
39. Current Strategies of Muscular Dystrophy Therapeutics: An Overview. Lim KRQ; Yokota T Methods Mol Biol; 2023; 2587():3-30. PubMed ID: 36401021 [TBL] [Abstract][Full Text] [Related]